Alaunos Therapeutics (TCRT) Current Deferred Revenue (2011 - 2018)
Alaunos Therapeutics' Current Deferred Revenue came in at $49.5 million for Q3 2018, up 674.8% from $6.39 million a year earlier and up 674.8% from the prior quarter.
Powered by 
Analysis
Alaunos Therapeutics (TCRT) Current Deferred Revenue (2011 - 2018) Analysis & Trends
At the end of FY2017, Alaunos Therapeutics' Current Deferred Revenue was $6.39 million, unchanged from FY2016.
- Current Deferred Revenue carries a five-year compound annual growth rate of 51.5% (FY2012 to FY2017).
- Going back by year, Current Deferred Revenue was $6.39 million in FY2016 (-6.9%), $6.86 million in FY2015 (+404.5%), $1.36 million in FY2014 (+70.0%) and $800,000 in FY2013 (unchanged).
- The Q3 2018 figure represents the highest quarterly Current Deferred Revenue in data going back to Q2 2011.
- Year-over-year, Current Deferred Revenue increased in 1 of the last eight quarters, with growth averaging 71.7%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q2 2016 (growth of 683.0%), and the weakest in Q1 2018 (a decline of 92.5%).
- Business Quant data shows TCRT's Current Deferred Revenue at $6.39 million (Q2 2018), $476,000 (Q1 2018) and $6.39 million (Q4 2017) in the three quarters before Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Alaunos Therapeutics | 2.19 Mn | -1.61 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 49.50 Mn |
| Jun 30, 2018 | 6.39 Mn |
| Mar 31, 2018 | 476,000.00 |
| Dec 31, 2017 | 6.39 Mn |
| Sep 30, 2017 | 6.39 Mn |
| Jun 30, 2017 | 6.39 Mn |
| Mar 31, 2017 | 6.39 Mn |
| Dec 31, 2016 | 6.39 Mn |
| Sep 30, 2016 | 6.39 Mn |
| Jun 30, 2016 | 6.39 Mn |
| Mar 31, 2016 | 6.49 Mn |
| Dec 31, 2015 | 6.86 Mn |
| Sep 30, 2015 | 6.93 Mn |
| Jun 30, 2015 | 816,000.00 |
| Mar 31, 2015 | 1.09 Mn |
| Dec 31, 2014 | 1.36 Mn |
| Sep 30, 2014 | 1.70 Mn |
| Jun 30, 2014 | 2.33 Mn |
| Mar 31, 2014 | 800,000.00 |
| Dec 31, 2013 | 800,000.00 |
API Access
Alaunos Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TCRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();